EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases

Dongyi Yu, Dairong Feng, Jiangbo Qu, Lei Nie, Qian Liu, Lu Gao, Wenzhen An, Na Liu, Yuying Fang

Frontiers in Genetics · 24.11.2025 · 16

DOI: 10.3389/fgene.2025.1662801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 24.11.2025. Verfasst von Dongyi Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics and Prenatal Diagnosis, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jin…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assessed the diagnostic effectiveness of trio-WES compared to CMA in fetuses with ultrasound anomalies and explored optimal prenatal testing strategies. A retrospective review included 454 fetuses who underwent trio-WES and/or CMA between 2020 and 2023. Cases were divided into four groups and 19 subgroups based on improvements in diagnosing ultrasound anomalies, demonstrating that trio-WES offers greater diagnostic value than CMA—especially for skeletal and multisystem defects, as well as ultrasound findings used to determine diagnostic yields. Trio-WES achieved a diagnostic yield of 22.7% (103/454), exceeding CMA by 17%. The highest diagnostic rates were observed in skeletal anomalies (39.2%) and multisystem anomalies (29.1%). Subgroup analysis showed higher yields in crystalline lens anomalies (60.0%) and cardiac rhabdomyoma (57.1%). Trio-WES significantly enhances prenatal diagnosis of ultrasound anomalies and provides additional diagnostic insights over CMA, particularly for skeletal, multisystem defects, and specific structural subgroups. Importantly, trio-WES helps clarify the mechanisms of ROH and assess its pathogenicity, aiding in detecting imprinted disorders. These findings support including trio-WES in prenatal testing protocols for congenital malformations and establish a framework for its clinical application.

Schlagwörter

Stichwörter der Autor:innen

chromosome disordersfetal ultrasound anomaliesmicroarray analysisprenatal diagnosissingle gene disorderswhole-exome sequencing

Autor:innen und Institutionen

  • Center for Medical Genetics and Prenatal Diagnosis, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.
  • Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Jinan, Shandong, China.
  • Key Laboratory of Maternal & Fetal Medicine of the National Health Commission, Jinan, Shandong, China.
  • Medical Management Service Center of Health Commission of Shandong Province, Jinan, Shandong, China.
  • Medical Department, Zhejiang Biosan Biochemical Technologies Co., Ltd, Hangzhou, Zhejiang, China.

Zitieren

APA

Yu, D., Feng, D., Qu, J., Nie, L., Liu, Q., Gao, L., An, W., Liu, N., & Fang, Y. (2025). Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases. Frontiers in Genetics, 16. https://doi.org/10.3389/fgene.2025.1662801

Vancouver

Yu D, Feng D, Qu J, Nie L, Liu Q, Gao L, et al. Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases. Frontiers in Genetics. 2025;16. doi:10.3389/fgene.2025.1662801

BibTeX
@article{Yu2025,
  author = {Yu, Dongyi and Feng, Dairong and Qu, Jiangbo and Nie, Lei and Liu, Qian and Gao, Lu and An, Wenzhen and Liu, Na and Fang, Yuying},
  title = {Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases},
  journal = {Frontiers in Genetics},
  year = {2025},
  volume = {16},
  doi = {10.3389/fgene.2025.1662801}
}
Kostenlos starten →